J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 77 (1996), 1287-1294; DOI 10.1099/0022-1317-77-6-1287
© 1996 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, R. A.
Right arrow Articles by Mackenzie, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, R. A.
Right arrow Articles by Mackenzie, J. S.
Agricola
Right arrow Articles by Hall, R. A.
Right arrow Articles by Mackenzie, J. S.

Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice

R. A. Hall1,2,*, T. N. H. Brand1, M. Lobigs3, M. Y. Sangster1,{dagger}, M. J. Howard1 and J. S. Mackenzie1,2,

1 Department of Microbiology, University of Western Australia, Nedlands, WA 6009
2 Department of Microbiology, University of Queensland, Brisbane, Qld 4072
and3 Division of Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia

The lack of an effective animal model has been a major obstacle in attempts to define the role of humoral and cellular immune responses in protection against flavivirus infection. We have used F1 hybrid mice (BALB/c x C3H/RV) that are heterozygous for the flavivirus resistance allele Flvr and show reduced virus replication in the brain after intracerebral inoculation. F1 hybrid mice challenged by intracerebral inoculation with Murray Valley encephalitis (MVE) virus developed encephalitis 2–3 days later than a genetically susceptible strain (BALB/c) but showed a similar mortality rate. This delay in the onset of disease provided more opportunity for virus clearance by primed immune responses. Using F1 hybrid mice we were able to demonstrate protective immunity induced by structural and non-structural proteins of MVE virus by immunization with pure NS1 protein or recombinant vaccinia viruses that expressed various regions of the MVE genome. These constructs included VV-STR (C-prM-E-NS1-NS2A), VV-{Delta}C (prM-E-NS1-NS2A) and VV-NS1 (NS1-NS2A). VV-{Delta}C vaccinated mice were completely protected (100% survival) from challenge with 1000 infectious units of MVE virus, while mice inoculated with VV-STR, VV-NS1 or pure NS1 were partially protected (40%, 47% and 85% respectively). Analysis of prechallenge sera and in vivo depletion studies revealed that the solid protection induced by VV-{Delta}C was mediated by neutralizing antibody to the E protein and did not require a CD8+ T cell response. The partial protection provided by VV-STR, VV-NS1 and pure NS1 occurred after induction of antibody to NS1. However, depletion of CD8+ cells prior to virus challenge ablated the protection provided by VV-NS1 indicating some requirement for class I restricted cytotoxic T cells.

* Author for correspondence Fax +61 7 33654620. e-mail royboy@biosci.uq.edu.au

{dagger} Present address: Department of Immunology, St Jude Children's Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.

Received 17 November 1995; accepted 16 February 1996.


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
D. C. Clark, M. Lobigs, E. Lee, M. J. Howard, K. Clark, B. J. Blitvich, and R. A. Hall
In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein
J. Gen. Virol., April 1, 2007; 88(4): 1175 - 1183.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. E. Calvert, C. Y.-H. Huang, R. M. Kinney, and J. T. Roehrig
Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge
J. Gen. Virol., February 1, 2006; 87(2): 339 - 346.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
E. Vizzi, E. Calvino, R. Gonzalez, I. Perez-Schael, M. Ciarlet, G. Kang, M. K. Estes, F. Liprandi, and J. E. Ludert
Evaluation of Serum Antibody Responses against the Rotavirus Nonstructural Protein NSP4 in Children after Rhesus Rotavirus Tetravalent Vaccination or Natural Infection
Clin. Vaccine Immunol., October 1, 2005; 12(10): 1157 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. G. M. Mathenge, M. d. C. Parquet, Y. Funakoshi, S. Houhara, P. F. Wong, A. Ichinose, F. Hasebe, S. Inoue, and K. Morita
Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice
J. Gen. Virol., September 1, 2004; 85(9): 2503 - 2513.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. Hall, D. J. Nisbet, K. B. Pham, A. T. Pyke, G. A. Smith, and A. A. Khromykh
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus
PNAS, September 2, 2003; 100(18): 10460 - 10464.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. M. Licon Luna, E. Lee, A. Mullbacher, R. V. Blanden, R. Langman, and M. Lobigs
Lack of both Fas Ligand and Perforin Protects from Flavivirus-Mediated Encephalitis in Mice
J. Virol., March 7, 2002; 76(7): 3202 - 3211.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. J. Blitvich, D. Scanlon, B. J. Shiell, J. S. Mackenzie, K. Pham, and R. A. Hall
Determination of the intramolecular disulfide bond arrangement and biochemical identification of the glycosylation sites of the nonstructural protein NS1 of Murray Valley encephalitis virus
J. Gen. Virol., September 1, 2001; 82(9): 2251 - 2256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 by the Society for General Microbiology.